A 50/50 strategic joint venture with Shanghai Xinhao Medical Technologies, headquartered in Shanghai — built to support medical technology development, commercialization, and market expansion across Asia, the Middle East, and international healthcare markets.
The Melhem Xinhao Medical Technologies joint venture brings together two organizations with complementary strengths — Melhem Medical Technologies' international network and the Melhem Holdings ecosystem, alongside Shanghai Xinhao Medical Technologies' position within one of the world's most dynamic medical technology markets.
Operating from Shanghai, the joint venture is positioned to support development, regulatory pathways, and commercialization across China and the broader Asian region, while extending into the Middle East and other international healthcare markets through Melhem's existing relationships.
The shared governance structure ensures both partners contribute to strategic direction, while day-to-day operations are designed to move quickly — matching the pace required in modern medical technology commercialization.